Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy

Completed · Phase 3 · Has a placebo group

Conditions studied: Diabetic Neuropathy, Painful

In brief

Patients will be switched from their current medication for painful diabetic peripheral neuropathy to evaluate the safety and efficacy of pregabalin as compared to placebo. All patients will receive pregabalin, and half of patients will receive placebo at some point during the study.

Key facts

Study ID
NCT01057693
Run by
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
People needed
633
Starts
2010-03-31
Expected to finish
2012-01-30
Last updated by the study team
2021-01-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.